Aradhia Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.90 M
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 52.88%
- Profit Growth 31.13%
- Ebitda 34.56%
- Net Worth 12.66%
- Total Assets 25.46%
About Aradhia Pharmaceuticals India
Aradhia Pharmaceuticals India Private Limited (APIPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 January 2019 (Six years and one month 6 days old ). Its registered office is in Amritsar, Punjab, India.
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.90 M, as per Ministry of Corporate Affairs (MCA) records.
Deepak Mishra, Anil Gupta, and Indu Gupta serve as directors at the Company.
Company Details
- Location
Amritsar, Punjab, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24111PB2019PTC048958
- Company No.
048958
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jan 2019
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Aradhia Pharmaceuticals India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Mishra  | Director | 18-Jan-2019 | Current |
| Anil Gupta | Director | 18-Jan-2019 | Current |
| Indu Gupta | Director | 18-Jan-2019 | Current |
Financial Performance of Aradhia Pharmaceuticals India.
Aradhia Pharmaceuticals India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 52.88% increase. The company also saw a substantial improvement in profitability, with a 31.13% increase in profit. The company's net worth Soared by an impressive increase of 12.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aradhia Pharmaceuticals India?
Unlock access to Aradhia Pharmaceuticals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Apellon Biotech Private LimitedIndu Gupta is a mutual person
Apellon Healthcare Private LimitedAnil Gupta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aradhia Pharmaceuticals India?
Unlock and access historical data on people associated with Aradhia Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aradhia Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aradhia Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.